Personal information

Emails & domains

Verified email addresses

Verified email domains

Websites & social links

Harvard Catalyst Profile
Google Scholor

Other IDs

ResearcherID: AAG-9554-2021
Loop profile: 560212
Scopus Author ID: 57190124483
SciProfiles: 1030738

Countries

United States

Activities

Collapse all

Employment (4)

Harvard Medical School: MA, MA, US

2023-01-01 to present | Instructor (Pediatrics)
Employment
Source: Self-asserted source
Akash Sabarwal

Boston Children's Hospital: Boston, US

2023-01-01 to present | Scientist/Faculty (Pediatrics)
Employment
Source: Self-asserted source
Akash Sabarwal

Boston Children's Hospital: Boston, MA, US

2018-11-01 to 2022-12-31 | Research Fellow (Nephrology)
Employment
Source: Self-asserted source
Akash Sabarwal

Jawaharlal Nehru University: New Delhi, New Delhi, IN

2017-03-10 to 2018-10-25 | Senior Research Fellow (Life Sciences)
Employment
Source: Self-asserted source
Akash Sabarwal

Education and qualifications (1)

Central University of Gujarat: Gandhinagar, Gujarat, IN

2011-09-05 to 2017-10-10 | Ph.D. (Life Sciences)
Education
Source: Self-asserted source
Akash Sabarwal

Professional activities (2)

European Association for Cancer Research: Nottingham, Nottinghamshire, GB

2015-02-01 to present | Ambassador
Membership
Source: Self-asserted source
Akash Sabarwal

American Association for Cancer Research: PA, PA, US

2022-09-29 to 2023-12-31 | Active Member
Membership
Source: Self-asserted source
Akash Sabarwal

Funding (2)

Investigatorship Award

2023-01 to 2027-12 | Award
Boston Children's Hospital (MA, MA, US)
Source: Self-asserted source
Akash Sabarwal

Targeting AXL to effectively inhibit c-Met and to overcome therapeutic-resistance in Renal Cancer

2022-09 to 2023-09 | Grant
Dana-Farber/Harvard Cancer Center (Boston, MA, US)
Source: Self-asserted source
Akash Sabarwal

Peer review (65 reviews for 33 publications/grants)

Review activity for Aging. (1)
Review activity for Annales pharmaceutiques françaises. (1)
Review activity for Biology. (1)
Review activity for Biomolecules. (3)
Review activity for BMC complementary medicine and therapies. (3)
Review activity for BMC pharmacology & toxicology. (1)
Review activity for Cancer reports. (1)
Review activity for Carcinogenesis. (2)
Review activity for Cells. (3)
Review activity for Cellular oncology. (1)
Review activity for Cellular oncology. (3)
Review activity for Clinical & translational oncology. (1)
Review activity for Clinical & translational oncology. (2)
Review activity for Current oncology. (1)
Review activity for Disease markers. (1)
Review activity for Food & function. (2)
Review activity for Frontiers in molecular biosciences. (1)
Review activity for Frontiers in pharmacology. (1)
Review activity for International journal of medical sciences[electronic resource]. (1)
Review activity for International journal of molecular sciences. (3)
Review activity for Journal of clinical medicine. (1)
Review activity for Life. (1)
Review activity for Medical oncology. (3)
Review activity for Medical oncology. (3)
Review activity for Medical sciences. (1)
Review activity for Molecular carcinogenesis. (2)
Review activity for Naunyn-Schmiedeberg's archives of pharmacology. (3)
Review activity for Oxidative medicine and cellular longevity. (6)
Review activity for Pathogens. (1)
Review activity for PloS one. (4)
Review activity for Processes. (2)
Review activity for Scientific reports. (2)
Review activity for Toxins. (3)
How many people are using ORCID?